Empagliflozin vs Irbesartan

Empagliflozin vs Irbesartan: Overview

This comparison examines the pharmacological differences between Empagliflozin and Irbesartan.

Mechanism of Action

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.

Pharmacokinetics

Half-life: Empagliflozin — 12.4 hours; Irbesartan — 11-15 hours.

Chemical Properties

Molecular Formula: Empagliflozin — C23H27ClO7; Irbesartan — C25H28N6O.

Molecular Weight: Empagliflozin — 450.9100 g/mol; Irbesartan — 428.5320 g/mol.

Type: Empagliflozin — Small molecule; Irbesartan — Small molecule.